Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis

Journal of Neuroimmunology

Volumn 138, Issue 1-2, 2003, Pages 76-82

  Deng, Caishu ^a,d   Wu, Bo ^a   Yang, Huan ^b   Hussain, Rehana Z ^a   Lovett Racke, Amy E ^a   Christadoss, Premkumar ^b   Racke, Michael K ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Acetylcholine receptor; Auto antibody; Experimental autoimmune myasthenia gravis; T cell activation; Tyrosine phosphatase

Indexed keywords

ANTIBODY; CHOLINERGIC RECEPTOR; GAMMA INTERFERON; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; TORPEDO ACETYLCHOLINE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CELL ASSAY; CELL PROLIFERATION; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG MECHANISM; ENZYME ANALYSIS; ENZYME DEFICIENCY; GENE DELETION; HETEROZYGOSITY; IMMUNIZATION; INCIDENCE; MOUSE; MOUSE STRAIN; MYASTHENIA GRAVIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SEQUENCE HOMOLOGY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

EID: 0037657515     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00119-X     Document Type: Article

References (48)

1. Ando D.G., Clayton J., Urban J.L., Sercarz E.E. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124(1):1989;132-143.
2. Balasa B., Deng C., Lee J., Bradley L.M., Dalton D.K., Christadoss P., Sarvetnick N. Interferon gamma (IFN-γ) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice. J. Exp. Med. 186(3):1997;385-391.
3. Balasa B., Deng C., Lee J., Christadoss P., Sarvetnick N. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis. J. Immunol. 161(6):1998;2856-2862.
4. Carter R.H., Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256:1992;105.
5. Carter J.D., Neel B.G., Lorenz U. The tyrosine phosphatase SHP-1 influences thymocyte selection by setting TCR signaling thresholds. Int. Immunol. 11:1999;1999.
6. Clark E.A., Shultz L.D., Pollack S.B. Mutations in mice that influence natural killer (NK) cell activity. Immunogenetics. 12:1981;601.
7. Deng C., Minguela A., Hussain R.Z., Lovett-Racke A.E., Radu C., Ward E.S., Racke M.K. Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis. J Immunol. 168(9):2002;4511-4518.
8. Doody G.M., Justement L.B., Delibrias C.C., Matthews R.J., Lin J., Thomas M.L., Fearon D.T. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science. 269(1995):1995;242.
9. Green M.C., Shultz L.D. Motheaten, an immunodeficient mutant of the mouse: I. Genetics and pathology. J. Heredity. 66:1975;250.
10. Jiao H., Yang W., Berrada K., Tabrizi M., Shultz L., Yi T. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction. Exp. Hematol. 25:1997;592.
11. Johnson K.G., LeRoy F.G., Borysiewicz L.K., Matthews R.J. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1. J. Immunol. 162:1999;3802.
12. v prothymocytes to generate thymocytes after intravenous transfer. J. Exp. Med. 166:1987;1162.
13. Kozlowski M., Mlinaric-Rascan I., Feng G.S., Shen R., Pawson T., Siminovitch K.A. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 178:1993;2157.
14. Lorenz U., Ravichandran K.S., Burakoff S.J., Neel B.G. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperresponsiveness. Proc. Natl. Acad. Sci. U. S. A. 93:1996;9624.
15. Lowin-Kropf B., Kunz B., Beermann F., Held W. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. J. Immunol. 165:2000;1314.
16. v) mutant mice: II. Description of a microenvironmental defect for the generation of terminal deoxynucleotidyltransferase-positive bone marrow cells in vitro. J. Immunol. 138:1987;3590.
17. Moiola L., Galbiati F., Martino G., Amadio S., Brambilla E., Comi G., Vincent A., Grimaldi L.M., Adorini L. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur. J. Immunol. 28:1998;2487.
18. Mosmann T.R., Coffman R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
19. Murphy E.E., Terres G., Macatonia S.E., Hsieh C.S., Mattson J., Lanier L., Wysocka M., Trnchieri G., Murphy K., O'Garra A. B7 and interleukine 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:1994;223-231.
20. Nakayama K., Takahashi K., Shultz L.D., Miyakawa K., Tomita K. Abnormal development and differentiation of macrophages and dendritic cells in viable motheaten mutant mice deficient in haematopoietic cell phosphatase. Int. J. Exp. Pathol. 78:1997;245.
21. Pani G., Fischer K.D., Mlinaric-Rascan I., Siminovitch K.A. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J. Exp. Med. 184:1996;839.
22. Pesando J.M., Bouchard L.S., McMaster B.E. CD19 is functionally and physically associated with surface immunoglobulin. J. Exp. Med. 170:1989;2159.
23. Plas D.R., Williams C.B., Kersh G.J., White L.S., White J.M., Paust S., Ulyanova T., Allen P.M., Thomas M.L. The tyrosine phosphatase SHP-1 regulates thymocyte positive selection. J. Immunol. 162:1999;5680.
24. Phee H., Rodgers W., Coggeshall K.M. Visualization of negative signaling in B cells by quantitative confocal microscopy. Mol. Cell Biol. 21(24):2001;8615-8625.
25. Poussin M.A., Goluszko E., Hughes T.K., Duchicella S.I., Christadoss P. Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR. J. Neuroimmunol. 111:2000;152.
26. Poussin M.A., Goluszko E., Franco J.U., Christadoss P. Role of IL-5 during primary and secondary immune response to acetylcholine receptor. J. Neuroimmunol. 125(1-2):2002;51-58.
27. Röcken M.M., Racke M., Shevach E.M. IL-4-induced immune deviation as antigen-specific therapy for inflammatory sutoimmune disease. Immunol. Today. 17:1996;225-231.
28. Sgroi D., Varki A., Braesch-Andersen S., Stamenkovic I. CD22 a B cell-specific immunoglobulin superfamily member, is a sialic acid-binding lectin. J. Biol. Chem. 268:1993;7011.
29. Shi F.D., Wang H.B., Li H., Hong S., Taniguchi M., Link H., Van Kaer L., Ljunggren H.G. Natural killer cells determine the outcome of B cell-mediated autoimmunity. Nat. Immunol. 1:2000;245.
30. Shultz L.D., Green M.C. Motheaten, an immunodeficient mutant of the mouse: II. Depressed immune competence and elevated serum immunoglobulins. J. Immunol. 116:1976;936.
31. Shultz L.D., Coman D.R., Bailey C.L., Beamer W.G., Sidman C.L. "Viable motheaten," a new allele at the motheaten locus: I. Pathology. Am. J. Pathol. 116:1984;179.
32. Shultz L.D., Rajan T.V., Greiner D.L. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol. 15:1997;302.
33. Sidman C.L., Shultz L.D., Unanue E.R. The mouse mutant "motheaten": I. Development of lymphocyte populations. J. Immunol. 121:1978;2392.
34. Sidman C.L., Shultz L.D., Unanue E.R. The mouse mutant "motheaten": II. Functional studies of the immune system. J. Immunol. 121:1978;2399.
35. + B cells in viable motheaten and normal mice. Science. 232:1986;1423.
36. Sidman C.L., Marshall J.D., Allen R.D. Murine "viable motheaten" mutation reveals a gene critical to the development of both B and T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 86:1989;6279.
37. Stamenkovic I., Sgroi D., Aruffo A., Sy M.S., Anderson T. The B lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T cells and alpha 2-6 sialyltransferase, CD75, on B cells. Cell. 66:1991;1133.
38. Tapley P., Shevde N.K., Schweitzer P.A., Gallina M., Christianson S.W., Lin I.L., Steinand R.B., Shultz L.D., Rosen J., Lamb P. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp. Hematol. 25:1997;122.
39. v). Exp. Hematol. 17:1989;81.
40. Vincent A., Drachman D.B. Myasthenia gravis. Adv. Neurol. 88:2002;159-188.
41. Westhoff C.M., Whittier A., Kathol S., McHugh J., Zajicek C., Shultz L.D., Wylie D.E. DNA-binding Abs from viable motheaten mutant mice: implications for B cell tolerance. J. Immunol. 159:1997;3024.
42. Wu B., Deng C., Goluszko E., Christadoss P. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis. J. Immunol. 159:1997;3016-3023.
43. Wu, B., Goluszko, E., Christadoss, P., 1997b. Murine model of experimental autoimmune myasthenia gravis. In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., Strober, W. (Eds.), Current Protocols in Immunology, Unit 15.8. Greene Publishing Associates and Wiley.
44. Yang H., Goluszko E., David C.S., Okita D.K., Conti-Fine B.M., Chan T.-S., Poussin M.A., Christadoss P. Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA-transgenic mice. J. Clin. Invest. 109:2002;1111-1120.
45. Yu C.C., Tsui H.W., Ngan B.Y., Shulman M.J., Wu G.E., Tsui F.W. B and T cells are not required for the viable motheaten phenotype. J. Exp. Med. 183:1996;371.
46. Zhang G.X., Bai X.F., van der Meide P.H., Orn A., Link H. Mice with IFN-γ receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis. J. Immunol. 162:1999;3775.
47. Zhang J., Somani A.K., Yuen D., Yang Y., Love P.E., Siminovitch K.A. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection. J. Immunol. 163:1999;3012.
48. Zhang J., Somani A.K., Siminovitch K.A. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin. Immunol. 12:2000;361.